143 related articles for article (PubMed ID: 9302258)
21. GAS41 amplification results in overexpression of a new spindle pole protein.
Schmitt J; Fischer U; Heisel S; Strickfaden H; Backes C; Ruggieri A; Keller A; Chang P; Meese E
Genes Chromosomes Cancer; 2012 Sep; 51(9):868-80. PubMed ID: 22619067
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
23. Direct interaction of Gas41 and Myc encoded by amplified genes in nervous system tumours.
Piccinni E; Chelstowska A; Hanus J; Widlak P; Loreti S; Tata AM; Augusti-Tocco G; Bianchi MM; Negri R
Acta Biochim Pol; 2011; 58(4):529-34. PubMed ID: 22068108
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
[TBL] [Abstract][Full Text] [Related]
26. Characterization of C4-2 as a tumor-suppressor gene in human brain tumors.
Sehgal A; Keener C; Boynton AL; Young RF; Vermeulen SS; Yonemura KS; Kohler EP; Aldape HC; Simrell CR; Murphy GP
J Surg Oncol; 1997 Feb; 64(2):102-8. PubMed ID: 9047245
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
[TBL] [Abstract][Full Text] [Related]
28. The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.
Tran NL; McDonough WS; Donohue PJ; Winkles JA; Berens TJ; Ross KR; Hoelzinger DB; Beaudry C; Coons SW; Berens ME
Am J Pathol; 2003 Apr; 162(4):1313-21. PubMed ID: 12651623
[TBL] [Abstract][Full Text] [Related]
29. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity of chromosome 10p in human gliomas.
Kimmelman AC; Ross DA; Liang BC
Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
[TBL] [Abstract][Full Text] [Related]
31. Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.
Maas RM; Reus K; Diesel B; Steudel WI; Feiden W; Fischer U; Meese E
Clin Cancer Res; 2001 Apr; 7(4):868-75. PubMed ID: 11309335
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
Leenstra S; Troost D; Westerveld A; Bosch DA; Hulsebos TJ
Cancer Res; 1992 Mar; 52(6):1568-72. PubMed ID: 1311634
[TBL] [Abstract][Full Text] [Related]
33. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
[TBL] [Abstract][Full Text] [Related]
34. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
35. Proto-oncogene analyses in brain tumors.
Fujimoto M; Sheridan PJ; Sharp ZD; Weaker FJ; Kagan-Hallet S; Story JL
J Neurosurg; 1989 Jun; 70(6):910-5. PubMed ID: 2541227
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
37. Familial glioma: a report of glioblastoma in identical twins and oligo-astrocytoma in siblings.
Hardman PD; Bell J; Whittle IR; Gregor A
Br J Neurosurg; 1989; 3(6):709-15. PubMed ID: 2697216
[TBL] [Abstract][Full Text] [Related]
38. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
Oskam NT; Bijleveld EH; Hulsebos TJ
Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
[TBL] [Abstract][Full Text] [Related]
39. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.
Louis DN; Rubio MP; Correa KM; Gusella JF; von Deimling A
J Neuropathol Exp Neurol; 1993 Sep; 52(5):507-15. PubMed ID: 8103086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
